FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308371391> ?p ?o ?g. }

• W4308371391 abstract "As multidrug and pan-resistance among Enterobacterales continue to increase, there is an urgent need for more therapeutic options to treat these infections. New β-lactam and β-lactam inhibitor (BLI) combinations have a broad spectrum of activity, but those currently approved do not provide coverage against isolates harboring metallo-β-lactamases (MBL). Aztreonam (ATM) and avibactam (AVI) in combination (ATM/AVI; AVI at 4 μg/mL fixed concentration) provides a similarly broad range of activity while maintaining activity against MBL-producing isolates. The in vitro susceptibility testing of ATM/AVI by standard methods was evaluated during development. This study investigated the impact of nonstandard testing conditions on the activity of ATM/AVI as observed during broth microdilution testing as well as the equivalency between agar dilution and broth microdilution MIC values when testing a diverse panel of Enterobacterales (N = 201). Nonstandard test conditions evaluated included inoculum density, atmosphere of incubation, media pH, varied medium cation concentrations, incubation time, varied serum concentrations, testing in pooled urine instead of media, addition of blood to the media, and the presence of surfactant. Generally, apart from low pH and high inoculum density, nonstandard testing parameters did not affect ATM/AVI broth microdilution MIC values. Correlation of MIC values obtained by agar dilution and broth microdilution resulted in an essential agreement of 97.0% for all tested Enterobacterales. Variation of standard testing conditions had little impact on broth microdilution MIC values for ATM/AVI. The correlation between broth microdilution and agar dilution MICs suggests both methods are reliable for determination of ATM/AVI MIC values. IMPORTANCE Increasing antibiotic resistance and emergence of pan-resistant isolates threaten the ability to control infections and to provide many other medical interventions such as surgery and chemotherapy, among others. New therapies are required to control emerging resistance mechanisms, including the increase in metallo-β-lactamases. Some new antibiotic combinations provide coverage against highly resistant isolates but are unable to target organisms that produce metallo-β-lactamases. Aztreonam in combination with avibactam provides a broad spectrum of activity against highly resistant isolates that also targets metallo-β-lactamase-producing organisms. An important part of drug development is the ability for clinical labs to determine the susceptibility of isolates to the antimicrobial. This manuscript investigates the in vitro susceptibility testing of aztreonam/avibactam with nonstandard testing conditions and a correlation study between broth microdilution and agar dilution against clinical isolates encoding a variety of resistance mechanisms. Overall, aztreonam/avibactam was generally unaffected by changes in testing conditions and showed strong agar/broth correlation." @default.
• W4308371391 created "2022-11-11" @default.
• W4308371391 creator A5013577208 @default.
• W4308371391 creator A5025477136 @default.
• W4308371391 creator A5030449858 @default.
• W4308371391 creator A5032266369 @default.
• W4308371391 creator A5033452961 @default.
• W4308371391 creator A5053134511 @default.
• W4308371391 creator A5065466073 @default.
• W4308371391 date "2022-12-21" @default.
• W4308371391 modified "2023-10-16" @default.
• W4308371391 title "Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales" @default.
• W4308371391 cites W1895007034 @default.
• W4308371391 cites W2136653513 @default.
• W4308371391 cites W2138209962 @default.
• W4308371391 cites W2152127318 @default.
• W4308371391 cites W2460245878 @default.
• W4308371391 cites W2463855494 @default.
• W4308371391 cites W2552167663 @default.
• W4308371391 cites W2574997685 @default.
• W4308371391 cites W2719132775 @default.
• W4308371391 cites W2918608884 @default.
• W4308371391 cites W2948401470 @default.
• W4308371391 cites W2983277151 @default.
• W4308371391 cites W3026777707 @default.
• W4308371391 cites W3115655908 @default.
• W4308371391 cites W3165714513 @default.
• W4308371391 cites W3193930247 @default.
• W4308371391 cites W3207503374 @default.
• W4308371391 cites W4206677002 @default.
• W4308371391 cites W4226129064 @default.
• W4308371391 cites W4242318543 @default.
• W4308371391 doi "https://doi.org/10.1128/spectrum.03601-22" @default.
• W4308371391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36342288" @default.
• W4308371391 hasPublicationYear "2022" @default.
• W4308371391 type Work @default.
• W4308371391 citedByCount "0" @default.
• W4308371391 crossrefType "journal-article" @default.
• W4308371391 hasAuthorship W4308371391A5013577208 @default.
• W4308371391 hasAuthorship W4308371391A5025477136 @default.
• W4308371391 hasAuthorship W4308371391A5030449858 @default.
• W4308371391 hasAuthorship W4308371391A5032266369 @default.
• W4308371391 hasAuthorship W4308371391A5033452961 @default.
• W4308371391 hasAuthorship W4308371391A5053134511 @default.
• W4308371391 hasAuthorship W4308371391A5065466073 @default.
• W4308371391 hasBestOaLocation W43083713911 @default.
• W4308371391 hasConcept C176947019 @default.
• W4308371391 hasConcept C185592680 @default.
• W4308371391 hasConcept C2778660310 @default.
• W4308371391 hasConcept C2780493024 @default.
• W4308371391 hasConcept C2780950330 @default.
• W4308371391 hasConcept C2909292399 @default.
• W4308371391 hasConcept C31903555 @default.
• W4308371391 hasConcept C43617362 @default.
• W4308371391 hasConcept C4937899 @default.
• W4308371391 hasConcept C523546767 @default.
• W4308371391 hasConcept C54355233 @default.
• W4308371391 hasConcept C86803240 @default.
• W4308371391 hasConcept C89423630 @default.
• W4308371391 hasConceptScore W4308371391C176947019 @default.
• W4308371391 hasConceptScore W4308371391C185592680 @default.
• W4308371391 hasConceptScore W4308371391C2778660310 @default.
• W4308371391 hasConceptScore W4308371391C2780493024 @default.
• W4308371391 hasConceptScore W4308371391C2780950330 @default.
• W4308371391 hasConceptScore W4308371391C2909292399 @default.
• W4308371391 hasConceptScore W4308371391C31903555 @default.
• W4308371391 hasConceptScore W4308371391C43617362 @default.
• W4308371391 hasConceptScore W4308371391C4937899 @default.
• W4308371391 hasConceptScore W4308371391C523546767 @default.
• W4308371391 hasConceptScore W4308371391C54355233 @default.
• W4308371391 hasConceptScore W4308371391C86803240 @default.
• W4308371391 hasConceptScore W4308371391C89423630 @default.
• W4308371391 hasFunder F4320306085 @default.
• W4308371391 hasFunder F4320333299 @default.
• W4308371391 hasIssue "6" @default.
• W4308371391 hasLocation W43083713911 @default.
• W4308371391 hasLocation W43083713912 @default.
• W4308371391 hasLocation W43083713913 @default.
• W4308371391 hasLocation W43083713914 @default.
• W4308371391 hasOpenAccess W4308371391 @default.
• W4308371391 hasPrimaryLocation W43083713911 @default.
• W4308371391 hasRelatedWork W1486807157 @default.
• W4308371391 hasRelatedWork W1964897829 @default.
• W4308371391 hasRelatedWork W2088438616 @default.
• W4308371391 hasRelatedWork W2153735834 @default.
• W4308371391 hasRelatedWork W2408776180 @default.
• W4308371391 hasRelatedWork W2513472555 @default.
• W4308371391 hasRelatedWork W2587629450 @default.
• W4308371391 hasRelatedWork W3030602969 @default.
• W4308371391 hasRelatedWork W3035613542 @default.
• W4308371391 hasRelatedWork W4253455759 @default.
• W4308371391 hasVolume "10" @default.
• W4308371391 isParatext "false" @default.
• W4308371391 isRetracted "false" @default.
• W4308371391 workType "article" @default.